Some visit links earn us a commission.
Quick verdict
Medvi is the better pick for most patients on overall scoring. Medvi runs a compounded-semaglutide and tirzepatide model at flat monthly pricing, with no lock-in and rapid intake. Comparable to Henry Meds and Mochi on price; less established clinical depth than Form Health or Knownwell. Best fit for cash-pay patients who want predictable monthly cost with minimal friction.
That said, Calibrate wins on specific dimensions. Calibrate is a coaching and insurance-navigation program whose value proposition has weakened as direct-to-consumer pricing from Lilly and Novo undercut the 'we'll handle insurance for you' pitch. Cut its fee from $299 to $199 in 2026.
Side-by-side
| Calibrate | Medvi | |
|---|---|---|
| Starts from | $224/mo (incl. medication) | $299/mo (incl. medication) |
| Monthly cost gap | Medvi is $45/mo cheaper than Calibrate | |
| Lock-in | 3-mo minimum | Month-to-month |
| Time to prescription | 14 days | 2 days |
| Consultation type | Live | Asynchronous |
| Affiliate network | Impact | Direct |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Calibrate | Medvi | |
|---|---|---|
| Pricing transparency | 5/10 | 8/10 |
| Cancellation terms | 6/10 | 8/10 |
| Onboarding experience | 4/10 | 7/10 |
| Medication options | 7/10 | 7/10 |
| Member reviews | 9.2/10 | 9/10 |
When to choose Calibrate
Best for committed behavioral coaching
Patients who specifically want behavioral coaching and have insurance that covers branded GLP-1s. Calibrate's clinicians and coaches handle prior authorization paperwork well.
Calibrate wins on member reviews on the dimensional scoring. The caveat: Cash-pay patients. With $597 upfront plus $199/mo plus medication separate, the all-in is rarely under $400/mo. Direct LillyDirect or NovoCare paths beat this on price. Note also: Restructured in 2024 amid demand declines
When to choose Medvi
Best for flat compounded with no lock-in
Cash-pay patients who want flat predictable compounded GLP-1 pricing with no lock-in and same-week onboarding. Strong fit if you've taken GLP-1 before and want a simple ongoing prescription channel.
Medvi wins on pricing transparency, cancellation terms, onboarding experience and runs $45/mo cheaper than Calibrate at the entry tier ($179 vs $224). Over a year that's $540 you keep. The caveat: Insurance-pathway shoppers, patients with multiple comorbidities needing clinical depth or anyone wanting branded Wegovy or Zepbound through standard PA. Note also: Compounded GLP-1 carries 503A regulatory exposure; see compounded callout
If cost is your main filter
Medvi is the cheaper monthly: $179 all-in vs $224 for Calibrate. That's $45 a month or $540a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $135 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Calibrate (3-mo minimum) and Medvi (month-to-month) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Medvi's easier cancellation is the safer trial.
FAQ
Is Calibrate cheaper than Medvi?
Can I switch from Calibrate to Medvi mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
